Sodium diethylcarbamodithioate trihydrate

Sodium diethylcarbamodithioate (Ditiocarb sodium) trihydrate is a copper reagent. The reaction with Cu²⁺ solution resulted in the formation of a complex, which increased the copper displacement precipitation rate. Sodium diethylcarbamodithioate trihydrate can reduce HIV infection and can be used in adjuvant immune research of high-risk breast cancer^[1][2][3]. In Vitro:Sodium diethylcarbamodithioate trihydrate reacts with the Cu²⁺ solution giving a complex of copper diethyldithiocarbamate, which enhances the rate of cementation^[1]. Sodium diethylcarbamodithioate trihydrate is an agent with strong antioxidant capacity and chelating activities^[2]. In Vivo:Sodium diethylcarbamodithioate trihydrate improves the depressed immune responses of newborn and aged mice. Sodium diethylcarbamodithioate trihydrate prevents cisplatin nephrotoxicity in animals without reducing the antitumor activity. In that AIDS model, Sodium diethylcarbamodithioate trihydrate reduces lymphadenopathy and hypergammaglobulinemia, restores immunocompetence, and prolongs survival^[2].